EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma

The EphA3 receptor has recently emerged as a functional tumour-specific therapeutic target in glioblastoma (GBM). EphA3 is significantly elevated in recurrent disease, is most highly expressed on glioma stem cells (GSCs), and has a functional role in maintaining self-renewal and tumourigenesis. An u...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cancers (Basel)
मुख्य लेखकों: Offenhäuser, Carolin, Al-Ejeh, Fares, Puttick, Simon, Ensbey, Kathleen S., Bruce, Zara C., Jamieson, Paul R., Smith, Fiona M., Stringer, Brett W., Carrington, Benjamin, Fuchs, Adrian V., Bell, Craig A., Jeffree, Rosalind, Rose, Stephen, Thurecht, Kristofer J., Boyd, Andrew W., Day, Bryan W.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI 2018
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6316644/
https://ncbi.nlm.nih.gov/pubmed/30562956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10120519
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन